No final decision has been made. If Walgreens decides to sell the unit, named iA, to interested parties such as rival healthcare organizations and private equity firms, it could make space for Summit Health, which Walgreens’ affiliate VillageMD bought for $8.9 billion in January, according to Bloomberg.
Walgreens’ iA is a pharmacy automation solutions segment that helps pharmacies fill prescriptions for mail-order transactions, according to its site.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.